AIM ImmunoTech’s Proxy Contest

Kirkland & Ellis advised AIM ImmunoTech on the deal.AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now